English | Español

Regulatory
+ Regulatory
Jeff Gantt | Dec 18, 2016

Afstyla approved by Health Canada
+ Regulatory
Jeff Gantt | Dec 18, 2016

Basaglar now available for prescription in U.S.
+ Regulatory
Jeff Gantt | Dec 17, 2016

AHA lends support to taxing sugary drinks based on sugar content
+ Regulatory
Keri Carbaugh | Dec 17, 2016

Vilsack responds to passage of 21st Century Cures Act
+ Regulatory
Jeff Gantt | Dec 17, 2016

Obama signs 'Christmas medical miracle' into law
+ Regulatory
Jeff Gantt | Dec 16, 2016

FDA issues statement on anesthesia use in young children, pregnant women
+ Regulatory
Jeff Gantt | Dec 16, 2016

NORD RAN releases second state report on rare diseases
+ Regulatory
Jeff Gantt | Dec 15, 2016

FDA issues warning letters over flavored cigarettes

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes